Amiodarone is one of the most commonly prescribed antiarrhythmic agents in clinical
practice owing to its efficacy, even with high toxicity profile. The high iodine content and the …

Amiodarone is an iodine‐based, potent antiarrhythmic drug bearing a structural
resemblance to thyroxine (T4). It is known to produce thyroid abnormalities ranging from …

Amiodarone, a benzofuranic iodine-rich pan-anti-arrhythmic drug, induces amiodarone-
induced thyrotoxicosis (AIT) in 7–15% of patients. AIT is a major issue due to its typical …

Introduction Amiodarone-induced thyrotoxicosis is associated with high morbidity and
mortality rates. The approach to this condition is widely variable across different medical …

Amiodarone-induced thyroid dysfunction occurs in 15–20% of amiodarone-treated patients.
Amiodarone-induced hypothyroidism (AIH) does not pose relevant problems, is easily …

The incidence of type 2 amiodarone-induced thyrotoxicosis (AIT) is increasing. A new study
provides evidence that glucocorticoid therapy is safe, effective and associated with prompt …

Amiodarone-induced thyrotoxicosis (AIT) are not uncommon endocrinopathies. Clinicians
are sometimes faced with difficult diagnostic and therapeutic situations. The disease …

Amiodarone-induced thyrotoxicosis (AIT) is a clinical condition fraught with difficulties and
uncertainties both from the diagnostic and therapeutic standpoints (1). Diagnosis and …

Background The incidence and risk factors of amiodarone-induced thyroid dysfunction are
variable in the literature. Objective The aim of this study was to investigate the clinical and …

Amiodarone is used increasingly in a number of cardiac conditions. Amiodarone is heavily
iodinated and can cause thyroid dysfunction. The diagnosis of amiodarone-induced …